companydata.dkcompanydata.dk

Novomedicon ApS: Financial statements 2025

CVR: 38818791

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Novomedicon ApS (CVR 38818791) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125. The solvency ratio was 0.7%.

Gross Profit
DKK -7,598
Profit/Loss
DKK -7,598
Equity
DKK 5,125
Total Assets
DKK 740,178
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--8K-8K5K0
2024--8K-8K13K1
2023--7K-7K20K1
2022--7K-7K28K-
2021---52235K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Novomedicon ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Novomedicon ApS: The 2024 annual report is outJun 30, 2025

Novomedicon ApS has published its annual report for 2024. Gross profit came to DKK -7,538, and the net result was DKK -7,538.

About Novomedicon ApS

Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.

Source: annual report 2025, Danish Business Authority

Other financial years